Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |